Amy Devlin

FDA investigator

Appears on 4 documents from 2019 to 2020, most often at sites in Illinois. Most often cites written procedures; deviations (21 CFR 211.100).

4
Documents on file
3.7
Observations per 483
2019
First seen
2020
Most recent

What they cite most

From 13 observations

Activity by year

2019: 3, 2020: 1

Where

Illinois 1 · Maryland 1 · Massachusetts 1 · North Carolina 1

Is Amy Devlin coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Human Genome Sciences, Inc.Jan 29, 2020 · Rockville, Maryland
483 Woodstock Sterile Solutions, Inc.Jun 25, 2019 · Woodstock, Illinois
483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCMay 3, 2019 · Andover, Massachusetts
483 FUJIFILM Diosynth Biotechnologies U.S.A., IncMar 1, 2019 · Morrisville, North Carolina

About this profile

What does Amy Devlin inspect?

Amy Devlin appears on 4 documents on file covering 4 sites, most often in Illinois.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.110.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Amy Devlin is dated Jan 29, 2020.

FDA Investigator Amy Devlin: 483s & Inspections · FDA Intel